Department of Radiological Examination and Technology, Tohoku University Graduate School of Medicine, 2-1, Seiryo-Machi, Aoba-Ku, Sendai, Miyagi 980-8575, Japan.
Department of Radiology, Sendai Kosei Hospital, 4-15, Hirose-Machi, Aoba-Ku, Sendai, Miyagi 980-0873, Japan.
J Radiol Prot. 2024 Sep 2;44(3). doi: 10.1088/1361-6498/ad6f19.
In response to the International Commission on Radiological Protection, which lowered the lens equivalent dose limit, Japan lowered the lens dose limit from 150 mSv yto 100 mSv/5 years and 50 mSv y, with this new rule taking effect on 1 April 2021. DOSIRISis a dosimeter that can accurately measure lens dose. Herein, we investigated lens dose in interventional cardiology physicians 1 year before and after the reduction of the lens dose limit using a neck dosimeter and lens dosimeter measurements. With an increase in the number of cases, both personal dose equivalent at 0.07 mm depth [Hp(0.07), neck dosimeter] and personal dose equivalent at 3 mm depth [Hp(3), lens dosimeter] increased for most of the physicians. The Hp(3) of the lens considering the shielding effect of the Pb glasses using lens dosimeter exceeded 20 mSv yfor two of the 14 physicians. Protection from radiation dose will become even more important in the future, as these two physicians may experience radiation dose exceeding 100 mSv/5 years. The average dose per procedure increased, but not significantly. There was a strong correlation between the neck dosimeter and lens dosimeter scores, although there was no significant change before and after the lens dose limit was lowered. This correlation was particularly strong for physicians who primarily treated patients. As such, it is possible to infer accurate lens doses from neck doses in physicians who primarily perform diagnostics. However, it is desirable to use a dosimeter that can directly measure Hp(3) because of the high lens dose.
针对国际放射防护委员会降低晶状体当量剂量限值的建议,日本将晶状体剂量限值从 150 mSv/年降低至 100 mSv/5 年和 50 mSv/年,新规定于 2021 年 4 月 1 日生效。DOSIRIS 是一种可以准确测量晶状体剂量的剂量计。在此,我们使用颈剂量计和晶状体剂量计测量了介入心脏病学医师在晶状体剂量限值降低前后 1 年的晶状体剂量。随着病例数量的增加,大多数医生的 0.07 毫米深度个人剂量当量[Hp(0.07),颈剂量计]和 3 毫米深度个人剂量当量[Hp(3),晶状体剂量计]均有所增加。对于 14 名医生中的 2 名,使用晶状体剂量计考虑到 Pb 眼镜的屏蔽效应,Hp(3)超过了 20 mSv/年。随着这些医生可能会经历超过 100 mSv/5 年的辐射剂量,未来对辐射剂量的防护将变得更加重要。每个手术的平均剂量有所增加,但并不显著。颈剂量计和晶状体剂量计的评分之间存在很强的相关性,尽管在晶状体剂量限值降低前后没有显著变化。对于主要治疗患者的医生,这种相关性尤为强烈。因此,可以推断出主要进行诊断的医生的颈剂量计的准确晶状体剂量。但是,由于晶状体剂量较高,最好使用可以直接测量 Hp(3)的剂量计。